Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 22
2015 184
2016 259
2017 244
2018 234
2019 223
2020 200
2021 177
2022 118
2023 82
2024 55

Text availability

Article attribute

Article type

Publication date

Search Results

1,523 results

Results by year

Filters applied: . Clear all
Page 1
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group. Primrose JN, et al. Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Lancet Oncol. 2019. PMID: 30922733 Free article. Clinical Trial.
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Chen QJ, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Su YH, Hua X, Wang XY, Hong RX, Jiang KK, Song CG, Huang ZZ, Shi W, Zhong YY, Yuan ZY; South China Breast Cancer Group (SCBCG). Wang X, et al. JAMA. 2021 Jan 5;325(1):50-58. doi: 10.1001/jama.2020.23370. JAMA. 2021. PMID: 33300950 Free PMC article. Clinical Trial.
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Chen YP, Liu X, Zhou Q, Yang KY, Jin F, Zhu XD, Shi M, Hu GQ, Hu WH, Sun Y, Wu HF, Wu H, Lin Q, Wang H, Tian Y, Zhang N, Wang XC, Shen LF, Liu ZZ, Huang J, Luo XL, Li L, Zang J, Mei Q, Zheng BM, Yue D, Xu J, Wu SG, Shi YX, Mao YP, Chen L, Li WF, Zhou GQ, Sun R, Guo R, Zhang Y, Xu C, Lv JW, Guo Y, Feng HX, Tang LL, Xie FY, Sun Y, Ma J. Chen YP, et al. Lancet. 2021 Jul 24;398(10297):303-313. doi: 10.1016/S0140-6736(21)01123-5. Epub 2021 Jun 7. Lancet. 2021. PMID: 34111416 Clinical Trial.
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.
Santhosh A, Sharma A, Bakhshi S, Kumar A, Sharma V, Malik PS, Pramanik R, Gogia A, Prasad CP, Sehgal T, Gund S, Dev A, Cheung WY, Pandey RM, Kumar S, Gupta I, Batra A; D-TORCH Trial Investigators. Santhosh A, et al. J Clin Oncol. 2024 May 20;42(15):1821-1829. doi: 10.1200/JCO.23.01730. Epub 2024 Feb 27. J Clin Oncol. 2024. PMID: 38412399 Clinical Trial.
Capecitabine-induced Leukoencephalopathy.
Yoshimura K, Tokunaga S, Daga H, Inoue M. Yoshimura K, et al. Intern Med. 2019 Feb 15;58(4):621-622. doi: 10.2169/internalmedicine.0961-18. Epub 2018 Oct 17. Intern Med. 2019. PMID: 30333392 Free PMC article. No abstract available.
Capecitabine leukoencephalopathy.
Yasiry Z, Obeda MS, Batty R, Sharrack B. Yasiry Z, et al. Pract Neurol. 2019 Jun;19(3):270-271. doi: 10.1136/practneurol-2018-002121. Epub 2019 Jan 5. Pract Neurol. 2019. PMID: 30612099 No abstract available.
Capecitabine-induced hyperammonemic encephalopathy.
Cerrella Cano C, Junquera Alonso E, Terroba Alonso M, Cano Calderero FX, Seoane Blanco L, Armesto González EM. Cerrella Cano C, et al. Rev Esp Enferm Dig. 2022 Jan;114(1):56. doi: 10.17235/reed.2021.8129/2021. Rev Esp Enferm Dig. 2022. PMID: 34154371 Free article.
[Capecitabine aggravating lentiginosis].
Idoudi S, Boussofara L, Belkahla M, Ghariani Fetoui N, Ghariani N, Belajouza C, Denguezli M. Idoudi S, et al. Therapie. 2021 May-Jun;76(3):253-255. doi: 10.1016/j.therap.2020.02.015. Epub 2020 Feb 21. Therapie. 2021. PMID: 32169288 French. No abstract available.
1,523 results